Synthesis and Antibacterial Activity of 3-(Morpholinopyridyl)-5-substituted Isoxazole Derivatives

被引:0
|
作者
Du, Guangjian [1 ]
Chen, Dongliang [1 ]
Lu, Ruijiong [1 ]
Wang, Xiaojun [1 ]
Yan, Ming [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Ind Inst Fine Chem & Synthet Drugs, Guangzhou 510006, Guangdong, Peoples R China
关键词
isoxazole derivative; synthesis; antibacterial activity; oxazolidinone antibacterial; RESISTANT STAPHYLOCOCCUS-AUREUS; OXAZOLIDINONE; IDENTIFICATION; AGENTS;
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A series of 3-(morpholinopyridyl)-5-substituted isoxazole derivatives were prepared starting from 6-chloropyridine-3-carbaldehyde. The structures of the products were confirmed by IR, NMR and MS data. The products have an isoxazole mother core with 3-morpholinopyridyl substitution and possess an approximately planar structure. In addition a number of ester groups, amino groups, triazole groups and oxazolidinone groups were introduced to 5-position of the isoxazole mother core. The antibacterial activities of the products against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermis, Enterococcus faecalis and Escherichia coli were studied. Inferior activities (MIC>32 mg/L) were observed in comparison with linezolid. The results imply that the lack of 5-sp(3) hybridization structure may result in the decrease of antibacterial activity of isoxazole derivatives.
引用
收藏
页码:1575 / 1581
页数:7
相关论文
共 14 条
  • [1] Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children
    Abi-Hanna, P
    Frank, AL
    Quinn, JP
    Kelkar, S
    Schreckenberger, PC
    Hayden, MK
    Marcinak, JF
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 630 - 631
  • [2] Identification of phenylisoxazolines as novel and viable antibacterial agents active against gram-positive pathogens
    Barbachyn, MR
    Cleek, GJ
    Dolak, LA
    Garmon, SA
    Morris, J
    Seest, EP
    Thomas, RC
    Toops, DS
    Watt, W
    Wishka, DG
    Ford, CW
    Zurenko, GE
    Hamel, JC
    Schaadt, RD
    Stapert, D
    Yagi, BH
    Adams, WJ
    Friis, JM
    Slatter, JG
    Sams, JP
    Oien, NL
    Zaya, MJ
    Wienkers, LC
    Wynalda, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) : 284 - 302
  • [3] Brickner SJ, 1996, CURR PHARM DESIGN, V2, P175
  • [4] Syntheses and antibacterial activity of a series of 3-(pyridine-3-yl)-2-oxazolidinone
    Cui, YJ
    Dang, YX
    Yang, YS
    Zhang, SH
    Ji, RY
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (02) : 209 - 214
  • [5] CYCLOADDITION REACTIONS OF NITRILE OXIDES WITH ALKENES
    EASTON, CJ
    HUGHES, CMM
    SAVAGE, GP
    SIMPSON, GW
    [J]. ADVANCES IN HETEROCYCLIC CHEMISTRY, VOL 60, 1994, 60 : 261 - 327
  • [6] Gallemi C. Farrerons, 2003, PCT Inc. Appl., Patent No. [2003008395, WO 2003008395 Al 20030130]
  • [7] Oxazolidinone antibacterial agents: A critical review
    Hutchinson, DK
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (09) : 1021 - 1042
  • [8] Treatment options for vancomycin-resistant enterococcal infections
    Linden, PK
    [J]. DRUGS, 2002, 62 (03) : 425 - 441
  • [9] Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000
    Mutnick, AH
    Biedenbach, DJ
    Turnidge, JD
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (01) : 65 - 73
  • [10] The synthesis of N-aryl-5(S)-aminomethyl-2-oxazolidinone antibacterials and derivatives in one step from aryl carbamates
    Perrault, WR
    Pearlman, BA
    Godrej, DB
    Jeganathan, A
    Yamagata, K
    Chen, JJ
    Lu, CV
    Herrinton, PM
    Gadwood, RC
    Chan, L
    Lyster, MA
    Maloney, MT
    Moeslein, JA
    Greene, ML
    Barbachyn, MR
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (04) : 533 - 546